Skip to main content
Clinical Trials/IRCT20181115041666N1
IRCT20181115041666N1
Not yet recruiting
Early Phase 1

Investigation of maternal and neonatal outcomes of expectant treatment in pregnant women with preterm premature rupture of membranes (PPROM) in hospital compared with expectant treatment at home

Mashhad University of Medical Sciences0 sites100 target enrollmentTBD

Overview

Phase
Early Phase 1
Intervention
Not specified
Conditions
preterm premature rupture of membranes.
Sponsor
Mashhad University of Medical Sciences
Enrollment
100
Status
Not yet recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • alive singleton pregnancy
  • Gestational age between 25 and 34 weeks
  • The absence of chorioamnionitis symptoms
  • The lack of evidence for fetal distress
  • No vaginal bleeding
  • Patient's consent
  • Evaluation for 72 hours in hospital
  • Cephalic presentation
  • Having a caretaker at home
  • Taking 60 minutes at most to reach the first treatment center

Exclusion Criteria

  • Occurrence of chorioamnionitis
  • disturbed fetal tests of health evaluation
  • Vaginal bleeding
  • Patient's unwillingness to continue participation in the study
  • Gestational age of less than 25 weeks of labor (greater than 3 cm of dilatation)

Outcomes

Primary Outcomes

Not specified

Similar Trials